Literature DB >> 30243096

PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.

Sikang Gao1, Junwu Hu1, Xiongwen Wu2, Zhihui Liang3.   

Abstract

Colon cancer is one of the most common digestive malignant tumors that leads to high mortality worldwide, and metastasis is the primary cause of cancer-related death. It is well accepted that the epithelial-mesenchymal transition (EMT) plays a key role in the process of metastasis. As a cytokine that macrophage secretes, IL-6 is involved in the progression of tumors, including the invasion and metastasis via kinds of signaling pathways. However, the mechanism of interactions between IL-6, macrophage, EMT and colon cancer is not fully understood. Increased CD68+ macrophages and IL-6 level were found in colon tumor as compared to normal colon tissue. Metastatic lymph node showed even more CD68+ macrophages and higher IL-6 level than the primary tumor. These results suggested that macrophages and IL-6 play an important role in EMT of colon cancer. In order to investigate the effect of macrophage and IL-6 on EMT of colon cancer, we cultured human colon carcinoma cell line SW48 with conditioned medium (CM) from PMA-stimulated monocyte THP-1 cells and tested for IL-6 dependent EMT pathways. Wound healing assay and Transwell assay were used to analyze cell migration and invasion. Results showed that CM-treated SW48 cells increased IL-6 production and displayed elevated capacity of migration and invasion compared to untreated cells. Increased expressions of EMT markers (N-cadherin, Vimentin and β-catenin) and decreased expression of EMT marker(E-cadherin) were found in CM-treated SW48 cells by Western Blot. The addition of an anti-IL-6 antibody significantly inhibited the increase of EMT markers (Vimentin and β-catenin) as well as cell migration and invasion, suggesting that IL-6 played a critical role in promoting EMT of CM-treated SW48 cells. In addition, we found that the levels of p-STAT3 and p-ERK increased in CM-treated SW48 compared to untreated cells, which can be reversed by AG490, an inhibitor of JAK. In the meantime, the suppression of JAK-associated signaling pathways caused a decrease of β-catenin. In summary, our study suggested that macrophage-induced IL-6 promotes migration and invasion of colon cancer cell via Wnt/β-catenin pathway in STAT3/ERK-dependent way.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colon cancer; EMT; ERK; IL-6; JAK; STAT3; β-Catenin

Mesh:

Substances:

Year:  2018        PMID: 30243096     DOI: 10.1016/j.biopha.2018.09.067

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  Protective roles of apremilast via Sirtuin 1 in atherosclerosis.

Authors:  Dongkui Sui; Hua Yu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Amandine Viau; Maroua Baaziz; Amandine Aka; Manal Mazloum; Clément Nguyen; E Wolfgang Kuehn; Fabiola Terzi; Frank Bienaimé
Journal:  J Am Soc Nephrol       Date:  2020-04-01       Impact factor: 10.121

Review 3.  Tumor-Associated Macrophages: Recent Insights and Therapies.

Authors:  Jiawei Zhou; Ziwei Tang; Siyang Gao; Chunyu Li; Yiting Feng; Xikun Zhou
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

Review 4.  Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review).

Authors:  Elena Niculet; Valentin Chioncel; Alina M Elisei; Magdalena Miulescu; Olimpia D Buzia; Lawrence C Nwabudike; Mihaela Craescu; Miruna Draganescu; Florin Bujoreanu; Elisabeta Marinescu; Manuela Arbune; Diana Sabina Radaschin; Carmen Bobeica; Aurel Nechita; Alin L Tatu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

5.  M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.

Authors:  Yuanhe You; Zhuowei Tian; Zhong Du; Kailiu Wu; Guisong Xu; Meilu Dai; Yan'an Wang; Meng Xiao
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06

6.  Gimap5 Inhibits Lung Cancer Growth by Interacting With M6PR.

Authors:  Pei Dai; Zhongxiang Tang; Pinglang Ruan; Ousman Bajinka; Dan Liu; Yurong Tan
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

7.  LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.

Authors:  Xiaobo Nie; Huiyang Liu; Wenling Ye; Xiaoyun Wei; Lili Fan; Han Ma; Lanqing Li; Wanting Xue; Wenting Qi; Yan-Dong Wang; Wei-Dong Chen
Journal:  J Cell Mol Med       Date:  2022-01-07       Impact factor: 5.310

Review 8.  The Role of Interleukins in Colorectal Cancer.

Authors:  Jingjing Li; Ling Huang; Hanzhang Zhao; Yuheng Yan; Jing Lu
Journal:  Int J Biol Sci       Date:  2020-06-14       Impact factor: 6.580

9.  Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer.

Authors:  Ashenafi Bulle; Jeroen Dekervel; Lise Deschuttere; David Nittner; Louis Libbrecht; Rekin's Janky; Stéphane Plaisance; Baki Topal; An Coosemans; Diether Lambrechts; Eric Van Cutsem; Chris Verslype; Jos van Pelt
Journal:  Transl Oncol       Date:  2020-03-04       Impact factor: 4.243

Review 10.  Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Authors:  Giovanni Barillari; Roberto Bei; Vittorio Manzari; Andrea Modesti
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.